Argenx Se (ARGX) Finished Goods (2021 - 2024)

Argenx Se (ARGX) posted quarterly Finished Goods of $38.4 million for Q2 2024, up 31.64% year-on-year from $29.2 million in Q3 2023, and up 69.66% on a QoQ basis from $22.6 million in Q4 2023.

Argenx Se (ARGX) Finished Goods (2021 - 2024) Analysis & Trends

Argenx Se (ARGX) has reported Finished Goods for 4 consecutive years, with $38.4 million the latest figure, recorded in Q2 2024.

  • Quarterly Finished Goods rose 31.64% year-over-year to $38.4 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $38.4 million (up 31.64% YoY) and the FY2023 annual result came in at $22.6 million, down 39.29% from the prior year.
  • Finished Goods improved to $38.4 million in Q2 2024 per ARGX's latest filing, from $22.6 million in the prior quarter.
  • Over the last five years, Finished Goods for ARGX reached as high as $38.4 million in Q2 2024 and fell as low as $1.2 million in Q4 2021.
  • A 4-year average of $24.9 million and a median of $25.9 million in 2023 frame the typical range for Finished Goods.
  • Annual changes were most pronounced in 2022 — Finished Goods surged 2914.63% — and 2023, when it plunged 39.29%.
  • Year by year, Finished Goods stood at $1.2 million in 2021, then jumped by 2914.63% to $37.3 million in 2022, then tumbled by 39.29% to $22.6 million in 2023, then jumped by 69.66% to $38.4 million in 2024.
  • According to Business Quant data, Finished Goods over the past three periods registered $38.4 million, $22.6 million, and $29.2 million for Q2 2024, Q4 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2024 38.41 Mn
Dec 31, 2023 22.64 Mn
Jun 30, 2023 29.18 Mn
Dec 31, 2022 37.29 Mn
Jun 30, 2022 20.91 Mn
Dec 31, 2021 1.24 Mn